Our founder shares his experience with the new HepQuant DuO test, which measures actual liver capacity, risk of complications, and shunting. A valuable tool for patients & doctors alike. Read more in our latest blog here: shorturl.at/mqdn2

Today, Fatty Liver Foundation proudly announces the Inaugural 2025 Dr. Stephen A. Harrison Patient Advocacy Fellows. From a highly competitive pool of applicants across the U.S., Canada, the U.K., and the EU, twenty remarkable Fellows have been selected to carry forward Dr.

Exactly one year ago, the idea for this Fellowship began as a vision to honor Dr. Stephen Harrison by creating a pathway for patient advocates to be recognized as equal partners in research, policy, and care. To see it realized today with the announcement of the Inaugural 2025

If you’ve ever felt alone in your steatotic liver disease journey—you’re not. The State of Steatotic (Fatty) Liver Care in America survey is a way to show how many of us share this road, even if our paths look different: shorturl.at/Ai2M4

When you see highly educated scientists and physicians (people with master’s degrees in public health and PhDs in their fields) completely disagreeing on a health topic (whether it’s diet, cholesterol, or vaccines), it should raise a red flag. Why? Because when experts who are

It should not be vastly easier to become licensed as a judge than licensed as a barber

Today in Paris, Fatty Liver Foundation introduced the Dr. Stephen A. Harrison Patient Advocacy Fellowship at The Liver Forum 19, marking the formal debut of this pioneering initiative before an international audience of regulators, academic leaders, innovators in drug and diagnostic

Yesterday at The Liver Forum 19 at the Institut Pasteur in Paris, Elena Samsonova, CMP, Manager of the Harrison Fellowship at Fatty Liver Foundation Fatty Liver Foundation, kicked off the meeting with an inspiring overview of the Dr. Stephen A. Harrison Patient Advocacy Fellowship. Úna Keightley

Here is me & my new pal & fellow fellow Just me Stevie 🤝 The Liver Forum in Paris We felt extremely welcome & listened to, while continuing to push for patient voices & lived experience to be heard on an international scale Read more on the legacy of Dr. Stephen A. Harrison here

I could not be more prouder to be involved in this event The Liver Forum Fatty Liver Foundation It’s been wonderful to meet Úna Keightley and we share very much the same vision. We have been made to feel so welcome to the Fellowship by Elena Samsonova and the other delegates.

🚨 Just 2 weeks left to submit your abstracts for HEP-DART 2025, celebrating its 30th anniversary this year under the visionary leadership of Prof. Raymond Schinazi. Informed Horizons Education, Inc. For three decades, HEP-DART has been a leading forum for advancing science and collaboration in

What do Ozempic and other GLP-1 treatments mean for people living with steatotic liver disease (SLD)? Find out in our next More Tomorrows webinar. Grab your spot: us02web.zoom.us/webinar/regist…

SLD and diabetes often go hand in hand and new GLP-1 treatments like Ozempic are changing the landscape. Join our webinar with Dr. Kenneth Cusi to explore what this means for patients. Register here: us02web.zoom.us/webinar/regist…

The future of SLD care is shifting. With new GLP-1 treatments and lifestyle strategies, patients have more options than ever. Join our free webinar to learn more. Sign up: us02web.zoom.us/webinar/regist…